| Liu, Xiaoqiang |
NCT04911790: Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults |
|
|
| Completed | 4 | 131650 | RoW | Experimental Group, CoronaVac | Sinovac Research and Development Co., Ltd. | COVID-19 | 01/23 | 08/23 | | |
NCT04992208: Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents |
|
|
| Completed | 4 | 31041 | RoW | Experimental Group, CoronaVac | Sinovac Life Sciences Co., Ltd. | COVID-19 | 03/23 | 08/23 | | |
NCT04644484: A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety |
|
|
| Completed | 3 | 1000 | RoW | SYN023, A Humanized Anti-Rabies Molecular antibodies cocktails, Human Rabies Immune Globulin (HRIG), Rabies Vaccine, Freeze-dried Rabies Vaccine for Human Use (Vero Cells) | Synermore Biologics (Suzhou) Co., Ltd., Simoon Record Pharma Information Consulting Co., Ltd. | Rabies, Communicable Disease, Virus Diseases, Rhabdoviridae Infections, Mononegavirales Infections, RNA Virus Infections | 06/22 | 12/22 | | |
| Completed | 3 | 1200 | RoW | GR1801, Human Rabies Immunoglobulin(HRIG), Rabies Vaccine | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Rabies Post-exposure Prophylaxis | 09/23 | 09/24 | | |
NCT06331156 / 2022-000708-36: A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants |
|
|
| Completed | 3 | 400 | RoW | HRV PCV-free, Rotarix PCV-free, IPV, Beijing Biological Products Institute Co.,Ltd.'s Inactivated Poliomyelitis Vaccine Made From Sabin Strains (Vero Cells) | GlaxoSmithKline, GlaxoSmithKline Biologicals SA | Gastroenteritis | 10/24 | 10/24 | | |
NCT06025695 / 2020-000972-38: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks |
|
|
| Completed | 3 | 2000 | RoW | GSK's liquid oral live attenuated HRV, Rotarix, PCV-free liquid formulation of GSK's oral live attenuated HRV, Rotarix PCV-free | GlaxoSmithKline, GlaxoSmithKline Biologicals SA | Gastroenteritis | 05/24 | 10/24 | | |
NCT04470609: Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years |
|
|
| Completed | 1/2 | 471 | RoW | Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule, Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule, High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule, Placebo on a 0- and 28-day schedule | Institute of Medical Biology, Chinese Academy of Medical Sciences, West China Second University Hospital, Yunnan Center for Disease Control and Prevention | COVID-19 | 10/20 | 10/21 | | |
NCT06482216: Correlation of Protection Against Varicella in an Exploratory Study |
|
|
| Not yet recruiting | N/A | 400 | NA | Varicella vaccine | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Varicella | 05/27 | 10/28 | | |
NCT04830826: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China |
|
|
| Recruiting | N/A | 2000 | RoW | Surgeries | The First Affiliated Hospital of Guangzhou Medical University | NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III | 01/24 | 07/24 | | |
